Sanofi to offer insulin product for $35 to all Americans through GoodRx
Publishing timestamp: 2023-10-19 10:31:02
Summary
Americans can now access Sanofi's Lantus insulin for $35 through GoodRx, regardless of their insurance status. This partnership aims to make the $35 price point more widely accessible, following insulin price cuts announced by Sanofi and its rivals earlier this year. However, some patients have struggled to access the $35 price point due to low awareness of patient savings programs.
Sentiment: NEUTRAL
Tickers: WBA, SAN-FR, CVS, WMT, NOVO.B-DK, GDRX, LLY,
Keywords: goodrx holdings inc, health care industry, business, walgreens boots alliance inc, sanofi sa, cvs health corp, pharmaceuticals, novo nordisk a/s, joe biden, united states, eli lilly and co, walmart inc, biotech and pharmaceuticals, breaking news, business news, biotechnology,
Source: https://www.cnbc.com/2023/10/19/sanofi-to-offer-insulin-for-35-to-americans-through-goodrx.html